Skip to Content

Hisamitsu Pharmaceutical Co Inc ADR HTSUY

Morningstar Rating
$7.76 −0.34 (4.20%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

HTSUY is trading at a 21% discount.
Price
$7.73
Fair Value
$9.57
Uncertainty
High
1-Star Price
$88.31
5-Star Price
$8.77
Economic Moat
Lsqyqk
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if HTSUY is a good fit for your portfolio.

Trading Information

Previous Close Price
$8.10
Day Range
$7.767.76
52-Week Range
$6.399.35
Bid/Ask
$6.37 / $6.45
Market Cap
$2.37 Bil
Volume/Avg
185 / 143

Key Statistics

Price/Earnings (Normalized)
24.86
Price/Sales
2.42
Dividend Yield (Trailing)
1.88%
Dividend Yield (Forward)
1.88%
Total Yield
4.90%

Company Profile

Hisamitsu Pharmaceutical Co Inc is a major pharmaceutical products manufacturer in Japan. The company collaborates with its subsidiaries and associates in operating its business across two segments, The Medical and Related Product segment and the Others segment. The Medical segment represents the company's foremost revenue generating operations. It markets drugs under the Salanpas, Salonsip, Lifecella, Mohrus and Keplat brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions and ointments. The Others segment refers to its miscellaneous businesses such as cable television broadcasting, internet connection, packing materials and insurance. Apart from its primary market in Japan, Hisamitsu has a reach across other regions like North America.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Mid Core
Total Number of Employees
3,643

Comparables

Valuation

Metric
HTSUY
4581
4569
Price/Earnings (Normalized)
24.8639.5727.47
Price/Book Value
1.300.840.84
Price/Sales
2.422.200.89
Price/Cash Flow
21.1014.6411.48
Price/Earnings
HTSUY
4581
4569

Financial Strength

Metric
HTSUY
4581
4569
Quick Ratio
3.304.201.33
Current Ratio
3.985.162.53
Interest Coverage
1,163.7368.7594.05
Quick Ratio
HTSUY
4581
4569

Profitability

Metric
HTSUY
4581
4569
Return on Assets (Normalized)
5.97%2.57%3.16%
Return on Equity (Normalized)
7.42%3.09%4.40%
Return on Invested Capital (Normalized)
6.39%2.64%3.57%
Return on Assets
HTSUY
4581
4569
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ZTS
Zoetis Inc Class ALbbphwtlbCwgk$77.2 Bil
MKKGY
Merck KGaA ADRZnfhzssnCqmknl$75.4 Bil
HLN
Haleon PLC ADRZkvnzlxDcnc$38.1 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRVdmspxqgFpdf$16.0 Bil
VTRS
Viatris IncDqzghgzBxb$14.0 Bil
RDY
Dr Reddy's Laboratories Ltd ADRXnhnlqkmLlrt$12.1 Bil
CTLT
Catalent IncYnxmxrbnWghrrrf$10.2 Bil
PRGO
Perrigo Co PLCVsxtsslRjm$4.3 Bil
CURLF
Curaleaf Holdings IncGmykkspZrs$4.0 Bil
PBH
Prestige Consumer Healthcare IncPfhkhksxBpmyq$3.6 Bil

Sponsor Center